[go: up one dir, main page]

WO2007009707A3 - Utilisation de composes a base de pyrazoline substitues pour le traitement de maladies liees a la coagulation - Google Patents

Utilisation de composes a base de pyrazoline substitues pour le traitement de maladies liees a la coagulation Download PDF

Info

Publication number
WO2007009707A3
WO2007009707A3 PCT/EP2006/006981 EP2006006981W WO2007009707A3 WO 2007009707 A3 WO2007009707 A3 WO 2007009707A3 EP 2006006981 W EP2006006981 W EP 2006006981W WO 2007009707 A3 WO2007009707 A3 WO 2007009707A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
related diseases
pyrazoline compounds
substituted pyrazoline
coagulation related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/006981
Other languages
English (en)
Other versions
WO2007009707A2 (fr
Inventor
Helmut H Buschmann
Saez Sergio Erill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05384023A external-priority patent/EP1743639A1/fr
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of WO2007009707A2 publication Critical patent/WO2007009707A2/fr
Publication of WO2007009707A3 publication Critical patent/WO2007009707A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a trait à l'utilisation de composés de pyrazoline substitués pour le traitement de maladies liées à la coagulation chez des humains et des animaux.
PCT/EP2006/006981 2005-07-15 2006-07-15 Utilisation de composes a base de pyrazoline substitues pour le traitement de maladies liees a la coagulation Ceased WO2007009707A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05384023A EP1743639A1 (fr) 2005-07-15 2005-07-15 Utilisation des derivés de la pyrazoline pour le traitement des troubles liées à la coagulation
EP05384023.7 2005-07-15
US70545705P 2005-08-05 2005-08-05
US60/705,457 2005-08-05

Publications (2)

Publication Number Publication Date
WO2007009707A2 WO2007009707A2 (fr) 2007-01-25
WO2007009707A3 true WO2007009707A3 (fr) 2007-04-19

Family

ID=37460152

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006981 Ceased WO2007009707A2 (fr) 2005-07-15 2006-07-15 Utilisation de composes a base de pyrazoline substitues pour le traitement de maladies liees a la coagulation

Country Status (2)

Country Link
ES (1) ES2327203B1 (fr)
WO (1) WO2007009707A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384477A1 (fr) * 2001-04-06 2004-01-28 Laboratorios Del Dr. Esteve, S.A. Utilisation de derives de pyrazolines dans l'elaboration d'un medicament pour la prevention et/ou le traitement de maladies proliferatives cellulaires
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
FR2861301A1 (fr) * 2003-10-24 2005-04-29 Sanofi Synthelabo Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique.
WO2005077911A1 (fr) * 2004-02-17 2005-08-25 Laboratorios Del Dr. Esteve S.A. Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments
WO2005077909A1 (fr) * 2004-02-17 2005-08-25 Laboratorios Dr. Esteve S.A. Composes de pyrazoline substitues permettant de reduire le taux de triglycerides dans le sang

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384477A1 (fr) * 2001-04-06 2004-01-28 Laboratorios Del Dr. Esteve, S.A. Utilisation de derives de pyrazolines dans l'elaboration d'un medicament pour la prevention et/ou le traitement de maladies proliferatives cellulaires
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
FR2861301A1 (fr) * 2003-10-24 2005-04-29 Sanofi Synthelabo Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique.
WO2005077911A1 (fr) * 2004-02-17 2005-08-25 Laboratorios Del Dr. Esteve S.A. Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments
WO2005077909A1 (fr) * 2004-02-17 2005-08-25 Laboratorios Dr. Esteve S.A. Composes de pyrazoline substitues permettant de reduire le taux de triglycerides dans le sang

Also Published As

Publication number Publication date
ES2327203B1 (es) 2010-06-07
WO2007009707A2 (fr) 2007-01-25
ES2327203A1 (es) 2009-10-26

Similar Documents

Publication Publication Date Title
ZA200804742B (en) Compounds for the treatment of inflammatory disorders and microbial diseases
IL191637A0 (en) Compounds for the treatment of inflammatory disorders and microbial diseases
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
ATE557021T1 (de) Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
CY2016015I1 (el) Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
WO2006119329A3 (fr) Compositions et procedes pour traiter des maladies neurodegeneratives
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE453642T1 (de) Substituierte phenylaminopyrimidine
EP1928453A4 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
WO2008076954A3 (fr) Composés hétérocycliques et procédés d'utilisation de ceux-ci
ATE537150T1 (de) Zur behandlung gynäkologischer erkrankungen geeignete pyrazolderivate
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
EP1924269A4 (fr) Composition a base d'eau de vegetation destinee au traitement d'affections cutanees inflammatoires
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007009701A3 (fr) Utilisation de composes pyrazoliniques substitues pour traiter des facteurs de risque cardiovasculaires imputables a des troubles du metabolisme ou de l'alimentation
WO2006109301A3 (fr) Molecules et procedes d'utilisation correspondants pour le traitement d'affections associees a mcp-1/ccr2
GB0523961D0 (en) The treatment of ophthalmic diseases
WO2006135694A3 (fr) Composes modulateurs d'uii et utilisation
WO2007009686A3 (fr) Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments
WO2007009707A3 (fr) Utilisation de composes a base de pyrazoline substitues pour le traitement de maladies liees a la coagulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 200850009

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: P200850009

Country of ref document: ES

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06762623

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 200850009

Country of ref document: ES

Kind code of ref document: A

WWG Wipo information: grant in national office

Ref document number: 200850009

Country of ref document: ES

Kind code of ref document: A